Considering Investing in Multifamily Real Estate? Here’s what we think you need to know. Learn the ins and outs of multifamily investing with our comprehensive guide. Start investing in multifamily real estate today on the CrowdStreet platform.
Our 2022 outlook for hospitality real estate As the hospitality industry moves into its next stage of pandemic recovery, we expect pent-up demand for travel, especially business-oriented, to drive demand for this asset class. Watch our Chief Investment Officer Ian Formigle discuss the opportunities ...
How Our Regained Mobility is Bringing Opportunity Back to Retail CrowdStreet's Ian Formigle talks about the surprising upside we're seeing in retail real estate and gives our outlook for this asset class.
How COVID Driven Migration is Driving Demand for Multifamily Projects Director of Investments Anna-Marie Alldner Lieb explains how COVID migration patterns have created strong demand for multifamily projects in new markets.
What the Shift to Hybrid Workforces Means for Office Real Estate CrowdStreet's Anna-Marie Allander Lieb details the state of office real estate and CrowdStreet's outlook for this asset class in 2021.
Why Industrial Real Estate is White Hot Post-Pandemic CrowdStreet's Ian Formigle explains how industrial real estate remained strong throughout the pandemic and gives our outlook on this asset class in 2021.
How a Reopening Economy is Impacting Investment Opportunities in Hospitality Ian Formigle breaks down how hospitality real estate is rebounding faster than expected and gives our outlook for this asset class in 2021.
The Best Cities for Investing in Multifamily Development Projects In the end, multifamily handled the 2020 recession better than most property sectors aside from industrial.
Why the Time is Right for Hotel to Multifamily Conversions Hotel-to-multifamily conversions can give distressed hotels a new life and add much-needed affordable housing units to tight markets.
CrowdStreet’s Life Science Roundtable CrowdStreet's Thomas McDonald sat down with Jay Doherty and Jay Hirsh to discuss the growth of the life science market and what to expect in the future.